ETON vs LNTH
Eton Pharmaceuticals, Inc. · Lantheus Holdings, Inc.
Relative return (rebased to 100)
Key stats
| Metric | ETON | LNTH |
|---|---|---|
| Price | $55.50 | $100.55 |
| Market Cap | $1.59B | $6.56B |
| P/E | — | 28.10 |
| P/B | 34.05 | 5.00 |
| P/S | 19.84 | 4.26 |
| ROE | -9.9% | 17.8% |
| Net Margin | -5.8% | 15.2% |
| Gross Margin | 53.5% | 61.1% |
| Revenue Growth | 104.9% | 0.5% |
| Dividend Yield | — | — |
| EPS | -$0.16 | $3.58 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.